Speakers
Christopher Abert, Allison Agwu, Christopher Bositis, R Douglas Bruce, Laura Fanucchi, Judith Feinberg, Daniel Griffin, Roy Gulick, Marwan Haddad, Hermione Hurley, Arthur Y-Shin Kim, D. Bryce McKinzie, Silvia Moscariello, Jamie Shank, David Spach, Melanie Thompson, Alice Thornton, David Wohl
Christopher Abert
Director
Southwest Recovery Alliance
Phoenix, Arizona
Christopher Abert is the founder and director of the Southwest Recovery Alliance and the Indiana Recovery Alliance. He is an advocate, community organizer, social service provider and is a HCV survivor. He has two decades of professional experience collaborating with people who use drugs, people living with HCV/HIV, survivors of domestic violence, at-risk youth, and people experiencing poverty and homelessness. He is a national harm reduction consultant, offering technical assistance and guidance to local communities to build functional capacity. He presents information on the human rights and public health benefits of Harm Reduction, and is passionate about utilizing evidence based, best practice, and compassionate approaches to drug use and disease prevention and elimination.
Allison Agwu, M.D., ScM, FAAP, FIDSA
Associate Professor of Adult and Pediatric Infectious Diseases
Johns Hopkins University (JHU) School of Medicine
Baltimore, Maryland
Allison Agwu, M.D., ScM is Associate Professor of Adult and Pediatric Infectious Diseases at Johns Hopkins University (JHU) School of Medicine. Dr. Agwu received her B.S. from University of Maryland, M.D. from University of Maryland School of Medicine, and Masters of Science from Johns Hopkins Bloomberg School of Public Health. She completed her internal medicine/pediatric residency at Case Western Reserve University and adult/pediatric infectious disease fellowship at Johns Hopkins School of Medicine. She cares for patients across the age spectrum, both in the pediatric and adult Ryan-White funded HIV clinics at Johns Hopkins, as the founder and medical director of the Accessing Care Early (ACE) Clinic and the Program Director of the Pediatric/Adolescent HIV/AIDS Program. Her clinical care and funded research focuses on deciphering health disparities and optimizing care and treatment strategies particularly for young people with HIV. She is a member of the U.S. Department of Health and Human Services’ Adolescent and Adult Antiretroviral Treatment Guidelines and serves on the Board of Directors for the HIV Medicine Association.
Christopher Bositis, MD, AAHIVS
Clinical Director of the HIV and Viral Hepatitis programs
Greater Lawrence Family Health Center
Lawrence, Massachusetts
Dr. Chris Bositis works at the Greater Lawrence Family Health Center in Lawrence, MA, where he is clinical director of the HIV and viral hepatitis programs, and a core member of the Lawrence Family Medicine Residency faculty. He is a graduate of the Yale University School of Medicine, and did his family medicine residency at Brown University/Memorial Hospital of Rhode Island. As a family physician working with historically marginalized and underserved communities that have suffered disproportionately from the overlapping opioid and infectious disease syndemics, he is committed to implementing evidence-based approaches to reduce the burden of these diseases in the community and to providing holistic, compassionate care to individuals living with them. As such, he has played a key role in the development and implementation of novel programs at Greater Lawrence, including their community-based syringe service program; the mobile buprenorphine program for individuals experiencing homelessness; the inpatient HIV and addiction medicine consult services; and the HIV/viral hepatitis area of concentration, which prepares family medicine residents to join the shrinking HIV workforce.
R Douglas Bruce, MD, MA, MSc
Associate Chief of Clinical Affairs, Medical Director of Primary Care
Boston University School of Medicine
Boston, Massachusetts
From academics to public/community health, Dr. Bruce has worked to develop and implement research and public health interventions both locally and internationally. Dr. Bruce is a global expert in substance use disorders among people with HIV/hepatitis C and serves as the substance use team lead for the Department of Health and Human Services Antiretroviral Guideline committee. From drug-drug interaction work to ascertain the impact of HIV and HCV therapeutics on methadone/buprenorphine and operations research to improve HIV/HCV and tuberculosis care, he has translated research into the clinical environments to improve outcomes for marginalized populations and reduce health disparities. Dr. Bruce has provided technical assistance to the CDC, United Nations, USAID, and non-governmental organizations to address HIV and substance use epidemics globally
In September 2020, Dr. Bruce moved to Boston to join Boston University School of Medicine and Boston Medical Center to continue practice transformation, innovation and quality improvement within a safety net organization’s large academic medical practice. Prior to that Dr. Bruce was the Chief of Medicine at Cornell Scott-Hill Health Center (CSHHC), where helped to transform the largest health center in New Haven with a focus on quality and value-based care which resulted in significant improvements in the delivery of clinical care, improvements in quality of care, and cost savings for CT Medicaid and the community. At the time of Dr. Bruce’s departure, the health center had generated over $4 million in savings for Connecticut Medicaid and was poised to assume operational control of the Internal Medicine and OB/GYN ambulatory practices and outpatient residency training of Yale New Haven Health. Prior to his role at CSHHC, Dr. Bruce was on the faculty of Yale School of Medicine in the Infectious Disease Section where he did research at the intersection of substance use disorders and infectious diseases.
Laura Fanucchi, MD, MPH
Associate Professor, Medicine, Infectious Disease
University of Kentucky College of Medicine and the Center on Drug and Alcohol Research
Director
UK Addiction Consult and Education Service
UK HealthCare
Lexington, Kentucky
Dr. Fanucchi earned an MD and MPH from Emory University, and completed an Internal Medicine residency and Chief Residency at New York-Presbyterian Hospital/Weill Cornell. She is board-certified in Internal Medicine and Addiction Medicine.
She provides treatment for opioid use disorder in the UK Bluegrass Care Clinic and in the UK First Bridge Clinic.
Dr. Fanucchi's research focus is in integrating evidence-based treatment of opioid use disorder in medically complex patient populations. She has presented regionally and nationally on the management of hospitalized patients with opioid use disorder and provides trainings to physicians and other members of the healthcare team.
Judith Feinberg, MD
E.B. Flink Vice Chair of Medicine for Research
Professor, Department of Behavioral Medicine and Psychiatry
Professor, Department of Medicine/Infectious Diseases
West Virginia University School of Medicine
Morgantown, West Virginia
Judith Feinberg, MD received her medical degree from Rush Medical College, Rush University, Chicago, IL. She served her residency at Rush-Presbyterian-St. Luke’s Medical Center in Chicago. Dr. Feinberg completed a fellowship in infectious diseases at the University of California, Los Angeles, and was a faculty member at Johns Hopkins and the University of Cincinnati before coming to West Virginia University in 2015. She is Professor of both Behavioral Medicine and Psychiatry and Medicine/Infectious Diseases, and Dr. E.B. Flink Vice Chair of Medicine for Research. She is certified by the American Board of Internal Medicine, Infectious Diseases.
She is a member of the American Academy of HIV Medicine, for which she serves on the Board of Directors, the HIV Medical Association, and the International AIDS Society.
Dr. Feinberg is a fellow of the Infectious Diseases Society of America and a reviewer for AIDS, Journal of the Acquired Immune Deficiency Syndromes, Journal of Infectious Diseases, and The New England Journal of Medicine, among many other scientific publications. She is Associate Editor of AIDS Clinical Care and the author or coauthor of more than 250 articles, abstracts, invited papers, and book chapters. She is a frequent lecturer on HIV infection and AIDS.
Daniel Griffin, MD, PhD, Ctrop
Columbia University Instructor of Medicine
ProHealth Care Chief of Infectious Disease
UnitedHealth Group-Senior Infectious Disease Fellow
Parasites without Borders-President
New York, New York
Dr. Griffin is an Instructor in Clinical Medicine, Division of Infectious Diseases, and Associate Research Scientist, Biochemistry and Molecular Biophysics at Columbia University. He is also active in the clinical care of patients living in the New York area, as well as a member of the Parasites without Borders team, which hosts the podcast TWiP (This Week in Parasitism) and a frequent guest on TWiV (This Week in Virology) Podcasts.
Roy Gulick, MD, MPH
Rochelle Belfer Professor of Medicine
Chief, Infectious Diseases
Weill Medical College of Cornell University Attending Physician
New York Presbyterian Hospital
New York, New York
Dr. Gulick is Rochelle Belfer Professor in Medicine and Chief of the Division of Infectious Diseases at Weill Cornell Medicine, and Attending Physician at the New York Presbyterian Hospital in New York City. He is board certified in internal medicine and infectious diseases.
Dr. Gulick’s research interests include designing, conducting and analyzing clinical trials to refine antiretroviral therapy strategies for HIV treatment and prevention and assess antiretroviral agents with new mechanisms of action. He currently serves as Principal Investigator of the Cornell-New Jersey HIV Clinical Trials Unit of the AIDS Clinical Trials Group (ACTG) and the HIV Prevention Trials Network (HPTN), sponsored by the U.S. National Institutes of Health.
He also serves as the Co-Chair of the U.S. Department of Health and Human Services (DHHS) Panel on Clinical Practices for Treatment of HIV Infection, a Board Member of the International Antiviral Society-USA, and previously served as a Member and as Chair of the Antiviral Drugs Advisory Committee of the U.S. Food and Drug Administration (FDA) and as a Member and as Chair of the NIH Office of AIDS Research Advisory Committee (OARAC). He most recently serves as the Co-Chair of the NIH COVID-19 Treatment Guidelines Panel. He is a Member of the American Society of Clinical Investigation, the Association of American Physicians, International AIDS Society, and the Infectious Diseases Society of America, and has presented at national and international meetings and published widely.
Marwan Haddad, MD, MPH, AAHIVS
Medical Director of the Center for Key Populations
Community Health Center, Inc. (CHCI)
Middletown, Connecticut
Marwan Haddad is currently the Medical Director of the Center for Key Populations at Community Health Center, Inc. (CHCI), one of the largest federally qualified health centers in the nation. The Center for Key Populations is the first center of its kind focused on engaging populations who traditionally experience barriers to comprehensive and respectful care secondary to stigma and discrimination. The Center brings together under one roof healthcare, training, research, and advocacy for the LGB (Lesbian, Gay, Bisexual) and Transgender communities, people who use drugs, the homeless and those experiencing housing instability, and the recently incarcerated. The Center oversees the HIV, Hepatitis C (HCV), Substance Use and Medication Assisted Treatment (MAT), Healthcare for the Homeless, and Sexually Transmitted Diseases programs among others at CHCI. Dr. Haddad joined CHCI in July 2006.
He received his Bachelor of Arts degree from Harvard University and his medical degree from McGill University. He completed his family medicine residency at University of Toronto and obtained his Masters in Public Health from Johns Hopkins University. He is board certified in Family Medicine. He is certified by the American Academy of HIV Medicine as an HIV specialist. He was also the recipient of the 2011 Primary Care Leadership Award presented by the Connecticut Center for Primary Care and was named Physician Health Care Hero of 2018 by the Hartford Business Journal. Dr. Haddad is an Assistant Clinical Professor of Family Medicine at Quinnipiac University. He currently serves as Chair-Elect of the HIV Medicine Association (HIVMA).
Since January 2012, Dr. Haddad has led the CHCI Weitzman ECHO HIV, HCV, and MAT programs which expand the integration of these programs not only within CHCI but nationwide. This model of care utilizes didactic and case-based learning via video conferences with medical providers, offering ongoing support, consultation and guidance to aid in delivering care to the HIV, HCV, and opioid-using populations. Dr. Haddad also provides technical assistance support to other health centers in setting up and enhancing integrated MAT programs across the country. Moreover, he has taught and lectured at state and national conferences on HIV, HCV, MAT and substance use management, and integrated care. He has published research on the integration of MAT in community health centers examining both substance use as well as primary care outcomes. He also has and continues to serve internationally as a consultant on HIV, HCV, opioid use disorder, integrated care, and virtual distance learning in Lesotho, Ukraine, Uganda, Jamaica, and Malaysia.
Hermione Hurley, MBChB
Assistant Professor, Medicine
University of Colorado
Aurora, Colorado
Physician
Center for Addiction Medicine, Denver Health and Hospital Authority and the Public Health Infectious Disease Clinic, Denver Health and Hospital Authority
Denver, Colorado
Dr. Hurley's interest in combining care delivery for substance use and infections began after observing poor outcomes for justice involved individuals.
Her current position is supported by Psychiatry and Medicine departments, enabling her to treat viral diseases in methadone clinics and substance use disorders in the Infectious Disease clinic for people living with HIV.
She earned her Engineering and Medical Degrees in New Zealand. Since immigrating to Colorado, she completed an Internal Medicine residency at St Joseph Exempla and fellowships in Infectious Disease and Addiction Medicine at the University of Colorado.
Arthur Y-Shin Kim, MD
Associate Professor, Medicine
Harvard Medical School
Director, Viral Hepatitis Clinic, Infectious Diseases
Massachusetts General Hospital
Boston, Massachusetts
Dr. Kim earned his MD from Harvard Medical School. After his internship and residency at Massachusetts General Hospital and fellowship in Infectious Diseases at MGH and Harvard Medical School, he joined the faculty at Harvard where he is currently Associate Professor of Medicine.
Dr. Kim is the Director of the Viral Hepatitis Clinic within the Division of Infectious Diseases at MGH and focuses his clinical and research interests on special populations with HCV, including those with HIV-1/HCV coinfection and in people who inject drugs. He recently completed a 3 year term as co-chair of the AASLD / IDSA Guidance Panel for Recommendations for Testing, Managing, and Treating Hepatitis C (available at hcvguidelines.org). He is a member of the DHHS Guidelines for the Use of Antiretroviral Agents in Adults and Adolescents Living with HIV. Since the pandemic, he has been leading institutional guidance for treatment of COVID-19 at MGH, is co-author of the UpToDate chapter regarding the care of hospitalized patients with COVID-19, and is a member of the NIH COVID-19 Treatment Guidelines Panel.
D. Bryce McKinzie
Employment and Income Navigator
Liberty Community Services
New Haven, Connecticut
Bryce McKinzie is an Employment and Income Navigator at Liberty Community Services in New Haven, CT. He has a BA in Psychology. He is pursuing his Master's in Clinical Mental Heath Counseling at Southern Connecticut State University. His goal is to work in higher education and apply the principles of POWER to college. He is also a HRSA SPNS author on a research study that produced the intervention that will be presented today. He has held progressive positions at Liberty through three research projects. In his current position, he helps people who are homeless or transient by motivating them to make progress through work, education, and volunteerism. He volunteers for multiple community organizations focused that promote justice and equity for marginalized populations
Silvia Moscariello, MBA
Director of Programs
Liberty Community Services, Inc.
New Haven, Connecticut
Silvia Moscariello, MBA is the Director of Programs for Liberty Community Services, Inc. in New Haven, Connecticut. She is a graduate of Post University with her graduate studies focused on leadership development. Her career spans over 40 years. Through progressive positions in the private nonprofit sector in Connecticut, Ms. Moscariello has designed and implemented interdisciplinary interventions for people who have been marginalized by disabilities, poverty, health barriers and justice involvement. These interventions have assisted people in stabilizing and advancing their housing, income and health. These innovative models have contributed to promising and evidence-based practices in housing, homeless and employment.
Jamie Shank, MPH
President & CEO
Organizational Empowerment LLC
Atlanta, Georgia
Jamie is a passionate public health professional with expertise in federal grant management, quality improvement, systems thinking, HIV care/treatment, and housing-related service provision. She received her Master of Public Health from Missouri State University before serving five years as the Quality & Housing Program Manager for the City of Kansas City, Missouri Health Department. Her responsibilities included managing the HIV Housing program portfolio including five federally funded contracts, multiple Special Projects of National Significance, and several IRB approved research projects. She also worked with Ryan White HIV care subrecipients, providing technical assistance and oversight for clinical quality management activities in the KC Metro Area and state of Missouri.
In April 2020 Jamie relocated to Atlanta, GA, and launched Organizational Empowerment, LLC. She’s currently working with the Center for Quality Improvement and Innovation’s create+equity campaign focused on disparities in care for homeless and unstably housed people living with HIV. She believes people working in the fields of public health and social services are the best people! Tackling intersectoral issues and empowering diverse teams to address complex problems motivate her work. You can contact Jamie here https://orgempower.com/
David Spach, MD
Professor of Medicine
Division of Infectious Diseases
University of Washington
Seattle, Washington
Dr. Spach is Professor of Medicine in the Division of Infectious Diseases at the University of Washington in Seattle. He is also the Principal Investigator and Clinical Director of the Mountain West HIV/AIDS Education and Training Center. He has published in numerous medical resources, including The New England Journal of Medicine, JAMA, The Annals of Internal Medicine, Emerging Infectious Diseases, The Journal of Infectious Diseases, and Up-to-Date. Dr. Spach is editor-in-chief of National HIV Curriculum (www.hiv.uw.edu), the National STD Curriculum (www.std.uw.edu), Hepatitis C Online (www.hepatitisC.uw.edu), Hepatitis B Online (www.hepatitisB.uw.edu), and the University of Washington IDEA Program: COVID-19 Treatment (https://covid.idea.medicine.uw.edu). He has received multiple teaching honors, including the Ryan White National AIDS Education and Training Center Award, the University of Washington Department of Medicine Paul Beeson teaching award, the Marvin Turck Outstanding Teaching Award, and the University of Washington Outstanding Faculty CME Award.
Melanie Thompson, MD
Principal Investigator
AIDS Research Consortium of Atlanta
Atlanta, Georgia
Dr. Melanie Thompson has conducted over 400 studies in the areas of HIV treatment, prevention and diagnostics; viral hepatitis treatment and diagnostics; sexually transmitted infection diagnostics, and epidemiology as Principal Investigator of the AIDS Research Consortium of Atlanta (ARCA). As an HIV clinician, she has cared for thousands of people with HIV in Atlanta since seeing her first patient in with HIV in 1982.
She currently co-chairs the HIV Medicine Association (HIVMA) HIV Primary Care Guidance Panel that recently published its 2020 recommendations for the clinical care of people with HIV in Clinical Infectious Diseases in November. She also serves on the US Department of Health and Human Services Antiretroviral Guidelines Panel and the IAS-USA (International Antiviral Society-USA) Antiretroviral Therapy Guidelines Panel, which she chaired in 2010 and 2012. She is a past chair of HIVMA and serves on the Ryan White Medical Coalition Steering Committee. At the state level, she is a member of the Georgia Department of Public Health’s HIV Medical Advisory Committee and its Legal and Ethical Committee. She served as Executive Editor of the “Strategy to End AIDS in Fulton County” created by the Fulton County Task Force on HIV/AIDS (2015-2017), and as Interim Chair of the Fulton County Prevention, Care, and Policy Advisory Committee (2019-2020).
Dr. Thompson’s passion is to contribute to an end to the HIV epidemic through patient-centered medical care, prevention and treatment research, and evidence-based guidelines and policy with a focus on health inequities.
Alice Thornton, MD
Professor, Medicine, Infectious Diseases
University of Kentucky College of Medicine
Chief, Infectious Disease
Project Director, Ryan White Part B, C, and D
Chair, KY AETC
UK HealthCare
Medical Director, Blue Grass Care Clinic
Lexington, Kentucky
Dr. Thornton earned an MD at Marshall University in Huntington, West Virginia. She completed residency at Wake Forest University School of Medicine in Internal Medicine. She then completed fellowship training with the Division of Infectious Disease at Indiana University Purdue University (IUPUI) where she studied the pathogenesis of chancroid. She was recruited to assist in the development of an Infectious Diseases Fellowship Program at the University of Kentucky in 1998.
Dr. Thornton has successfully acquired four HRSA funded grants – Ryan White Part B, C and D and the Local Performance Site grant of the Southeast AIDS Training and Education Center. She serves as Medical Director of the Blue Grass Care Clinic. She is PI of the NIH-funded Reprieve Study – Randomized Clinical Trial to Prevent Vascular Events in HIV.
Dr. Thornton is a clinical site visitor for HRSA and also serves as a grant reviewer for the Health Resources and Services Administration (HRSA), National Institutes of Health (NIH), and the Centers for Disease Control and Prevention (CDC). She serves on the HIVMA Board of Directors.
David Wohl, MD
Associate Professor, Medicine
University of North Carolina School of Medicine
Co-Director, HIV Services
North Carolina Department of Corrections
Director, North Carolina AIDS Education and Training Center
Chapel Hill, North Carolina
Dr. Wohl is the Site Leader of the UNC AIDS Clinical Trials Unit at Chapel Hill and Co-Directs HIV Services for the North Carolina Department of Correction. In 2011, Dr. Wohl also became Director of the North Carolina AIDS Education and Training Center (AETC).
Dr. Wohl’s research aims to optimize the treatment of HIV including identification of most effective therapeutic approaches and minimizing adverse effects of therapy. He also is active in investigations focused on the nexus between incarceration and the HIV epidemic. He has chaired several related AIDS Clinical Trials Group (ACTG) and independent studies and receives NIH funding for his corrections related research.
Dr. Wohl serves as a member of the Department of Health and Human Services (DHHS) HIV treatment guidelines panel. In addition to his research and administrative activities, Dr. Wohl maintains a large HIV continuity clinic at UNC and sees patients at the NC state prison.
Dr. Wohl earned an MD from the Robert Wood Johnson Medical School in Camden, New Jersey. He completed residency in Internal Medicine at the Duke University Medical Center and an Infectious Diseases Fellowship at UNC-Chapel Hill.
He is certified by the Internal Medicine ABIM, 1995-2005, and Board Certified Infectious Diseases, 2000.